Author: CSN
Why Curaleaf Stock Rocked the Market Today
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182 % for…
CV Sciences Sales Down 10 Percent
Operating income turned positive, mostly due to a $0.5 million one-time benefit, with actual operating income of $11,000, but adjusted…
MSOS: Cannabis Stocks Soar On Possible Rescheduling, But It’s Time To Sell (Downgrade)
Top holdings in MSOS face declining revenues, shrinking margins, and high leverage. Click here to find out why MSOS is…
NY cannabis program ruling could add to legal case for interstate commerce
The Second Circuit ruling has essentially zero immediate impact for stakeholders in the New York cannabis market, since it doesn’t…
This Cannabis Stock Popped 26% Today After Announcing Partnership With An Italian Company – Do You Own It?
Tilray Brands’ (TLRY) shares soared over 26% by Wednesday afternoon after Tilray Medical announced that its wholly-owned subsidiary has entered…
Rescheduling Should Send MJ And MSOS Sky High
Cannabis ETFs MJ and MSOS are surging on rescheduling speculation that Trump will reclassify marijuana as a Schedule III drug….
2 Stocks Down More Than 90% That Still Aren’t Worth Buying
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182% for the…
Why cannabis insurability depends on the story you tell
Operators who humanize their risk profile are finding more receptive underwriters and better terms, says Kelli Hunt …
Why This Cannabis Penny Stock Could Be Wall Street’s Next Meme Trade Breakout
The cannabis industry has been through one of the longest bear markets in recent history. But in the past few…
Neural Therapeutics Acquires Stake in German CBD Retailer Hanf.com
An announcement from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics Inc. has completed the acquisition of…
Recent Comments